MX2020006280A - Una composición tópica basada en un derivado de niacinamida. - Google Patents

Una composición tópica basada en un derivado de niacinamida.

Info

Publication number
MX2020006280A
MX2020006280A MX2020006280A MX2020006280A MX2020006280A MX 2020006280 A MX2020006280 A MX 2020006280A MX 2020006280 A MX2020006280 A MX 2020006280A MX 2020006280 A MX2020006280 A MX 2020006280A MX 2020006280 A MX2020006280 A MX 2020006280A
Authority
MX
Mexico
Prior art keywords
topical composition
composition based
niacinamide
derivative
niacinamide derivative
Prior art date
Application number
MX2020006280A
Other languages
English (en)
Other versions
MX387859B (es
Inventor
Balu Kunjupillai
Amitabha Majumdar
Khushbu Agarwal
Vijay Ramchandra Gadgil
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2020006280A publication Critical patent/MX2020006280A/es
Publication of MX387859B publication Critical patent/MX387859B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se relaciona con una composición tópica que comprende un compuesto de la fórmula (I) en donde R es un grupo cicloalquilo con el número total de átomos de carbono en el grupo cicloalquilo en el rango de 4 a 6.
MX2020006280A 2017-12-18 2018-12-17 Una composición tópica basada en un derivado de niacinamida. MX387859B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17208131 2017-12-18
PCT/EP2018/085269 WO2019121548A1 (en) 2017-12-18 2018-12-17 A topical composition based on niacinamide derivative

Publications (2)

Publication Number Publication Date
MX2020006280A true MX2020006280A (es) 2021-11-12
MX387859B MX387859B (es) 2025-03-19

Family

ID=60673832

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006280A MX387859B (es) 2017-12-18 2018-12-17 Una composición tópica basada en un derivado de niacinamida.

Country Status (6)

Country Link
US (1) US20200316050A1 (es)
EP (1) EP3727316B1 (es)
CN (1) CN111683649B (es)
BR (1) BR112020010720B1 (es)
MX (1) MX387859B (es)
WO (1) WO2019121548A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023031407A1 (en) 2021-09-06 2023-03-09 Unilever Ip Holdings B.V. A deodorant composition
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
EP4577044A1 (en) * 2022-08-25 2025-07-02 Unilever IP Holdings B.V. Inactivation or kill of virus and compositions thereof
WO2025036792A1 (en) 2023-08-14 2025-02-20 Unilever Ip Holdings B.V. Deodorant compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822277A (en) * 1967-11-13 1974-07-02 C Dufour Certain pyridyl cyclopropylamides
US3464998A (en) * 1968-03-04 1969-09-02 Searle & Co Adamantyl esters and amides of pyridinecarboxylic acids
AU5706301A (en) * 2000-04-14 2001-10-30 Niadyne Corp Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
US20110123510A1 (en) * 2009-09-24 2011-05-26 Washington University Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis
BR112016024400A2 (pt) 2014-05-12 2017-08-15 Unilever Nv uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo
CN113242751B (zh) * 2018-12-18 2023-09-19 联合利华知识产权控股有限公司 抗微生物组合物

Also Published As

Publication number Publication date
WO2019121548A1 (en) 2019-06-27
US20200316050A1 (en) 2020-10-08
BR112020010720A2 (pt) 2020-11-10
BR112020010720B1 (pt) 2023-11-14
EP3727316B1 (en) 2021-10-13
EP3727316A1 (en) 2020-10-28
CN111683649B (zh) 2025-07-08
CN111683649A (zh) 2020-09-18
MX387859B (es) 2025-03-19

Similar Documents

Publication Publication Date Title
MX2020006280A (es) Una composición tópica basada en un derivado de niacinamida.
PH12014501871A1 (en) Pest control composition including novel iminopyridine derivative
MY177574A (en) New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
AU2018274723A1 (en) Benzimidazolone derived inhibitors of BCL6
MX2015013530A (es) Mezclas de alquilpoliglucósidos, su preparacion y sus usos.
WO2014191258A3 (en) Antimicrobial compositions comprising glyceryl ethers
NZ710052A (en) Novel pyrazol derivatives
PH12015502097B1 (en) Novel compounds and compositions for inhibition of fasn
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
PH12016500148B1 (en) Plant disease control composition and its use
PH12016500146B1 (en) Plant disease control composition and its use
PH12012501385A1 (en) Piperazine compound having a pgds inhibitory effect
BR112012019345A2 (pt) composições de etanol.
PH12020552152A1 (en) Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
MY171768A (en) Process and composition for inhibiting the polymerization of cyclopentadiene compounds
SG10201805896SA (en) PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
MX360734B (es) Composición microbicida que comprende una sal benzoato o sorbato.
MY185971A (en) Pyranodipyridine compound
JOP20200030A1 (ar) مركب خماسي الحلقة
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
MX2015007309A (es) Derivado de hidantoina.
MY193239A (en) Novel b-lactamase inhibitors
MY169869A (en) Pyrrolidine-3-ylacetic acid derivative
GB2524620A (en) Light-emitting compound
FI20185841A1 (fi) Makrosykliset yhdisteet ja niiden käytöt